BRIEF published on 07/24/2024 at 12:35, 2 years ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Merger Financing Nasdaq Biopharmaceutical QTORIN™
BRIEF published on 07/24/2024 at 12:35, 2 years ago Palvella Therapeutics et Pieris Pharmaceuticals annoncent un accord de fusion définitif Financement Nasdaq Biopharmaceutique Fusionnement QTORIN™
PRESS RELEASE published on 07/24/2024 at 12:30, 2 years ago Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement Palvella Therapeutics, Inc. and Pieris Pharmaceuticals, Inc. announce a merger to focus on rare genetic skin diseases with QTORIN™ rapamycin. Joint webcast on July 24 at 8:30am ET Merger Clinical-stage Genetic Skin Diseases QTORIN™ Rapamycin FDA-approved Therapies
BRIEF published on 04/19/2024 at 18:15, 2 years 3 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Reverse Stock Split Nasdaq Compliance Financial Regulation Pieris Pharmaceuticals Stock Adjustment
BRIEF published on 04/19/2024 at 18:15, 2 years 3 months ago Pieris Pharmaceuticals annonce un regroupement d'actions de 1 pour 80 Réglementation Financière Pieris Pharmaceutique Regroupement D'actions Inversé Conformité NASDAQ Ajustement Des Stocks
PRESS RELEASE published on 04/19/2024 at 18:10, 2 years 3 months ago Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split Pieris Pharmaceuticals, Inc. announces a 1-for-80 reverse stock split effective on April 22, 2024, to comply with Nasdaq listing requirements. No fractional shares will be issued Reverse Stock Split Compliance Nasdaq Pieris Pharmaceuticals Stockholder Ownership
BRIEF published on 03/27/2024 at 13:05, 2 years 3 months ago Pieris Pharmaceuticals Announces New Strategy to Maximize Financial Potential Shareholder Value Pieris Pharmaceuticals Strategic Reorganization Milestone Payments Royalty Potential
BRIEF published on 03/27/2024 at 13:05, 2 years 3 months ago Pieris Pharmaceuticals annonce une nouvelle stratégie pour maximiser le potentiel financier Valeur Pour Les Actionnaires Pieris Pharmaceutique Réorganisation Stratégique Paiements D'étape Potentiel De Redevances
PRESS RELEASE published on 03/27/2024 at 13:00, 2 years 3 months ago Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential Pieris Pharmaceuticals, Inc. announces strategic repositioning to maximize milestone and royalty potential from immuno-oncology assets. Cost-saving measures extend cash runway into 2027 Strategic Repositioning Cost-saving Measures Pieris Pharmaceuticals Milestone Payments Immuno-oncology Assets
Published on 07/24/2026 at 23:00, 1 day 1 hour ago NV Gold Announces Closing of Non-Brokered Private Placement
Published on 07/24/2026 at 22:15, 1 day 2 hours ago Gold Terra Announces Closing of First Tranche of C$10.8M LIFE Offering With Strong Participation From Strategic Shareholder David Harquail
Published on 07/24/2026 at 22:05, 1 day 2 hours ago Findev Inc. Announces CCAA Proceedings Involving 1682 Victoria Park Avenue Inc. and Related Party Subordination Arrangement
Published on 07/24/2026 at 20:00, 1 day 4 hours ago Unusual Machines to Announce Second Quarter 2026 Financial Results and Provide Corporate Update
Published on 07/24/2026 at 18:44, 1 day 6 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 07/24/2026 at 18:15, 1 day 6 hours ago EUROPLASMA: Tirage des deux premières tranches du financement obligataire en vue de l’émission de 400 obligations convertibles en actions nouvelles pour un montant nominal de 2 M€
Published on 07/24/2026 at 17:50, 1 day 6 hours ago Fuller, Smith & Turner PLC: Director / PDMR Shareholding
Published on 07/25/2026 at 07:00, 17 hours 46 minutes ago DLSI - Chiffre d'affaires 1er semestre 2026
Published on 07/24/2026 at 18:50, 1 day 5 hours ago Disclosure of transactions in own shares from July 20 to July 24, 2026
Published on 07/24/2026 at 18:50, 1 day 5 hours ago Déclaration hebdomadaire d'opérations effectuées du 20 au 24 juillet 2026
Published on 07/24/2026 at 18:23, 1 day 6 hours ago Communiqué relatif au dépôt d'offre publique de retrait visant les actions Bourrelier Group
